Clinical Trial: Evaluating Novel Therapies in ctDNA Positive GI Cancers
Study Status: Completed
Recruit Status: RECRUITING
Condition: Colon Adenocarcinoma
Study Type: INTERVENTIONAL
Official Title: Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease
Brief Summary:
This study is a non-randomized, open-label, multi-cohort, multi-site, pilot feasibility therapeutic trial.The study will enroll 20 patients across 4 cohorts (CRC, gastric, PDAC, and HCC/intra-hepatic-/extra-hepatic-, gall bladder adenocarcinomas) diagnosed with histologically confirmed GI cancers.These patients will have already completed all Standard of Care (SOC) treatments (including neoadjuvant, surgery, local therapies, and/or adjuvant therapy as applicable), as defined by the treating primary…
Read more